Completed OBSERVATIONAL NCT03979937

Development and Validation of a Simple Diagnostic Tool Predictive of the Aseptic Character of Joint Effusion (PRASEPT)

Sponsor: Centre Hospitalier le Mans

Conditions Arthritis Joint Effusion Septic Arthritis

Updated 7 times since 2019 Last updated: Mar 8, 2022 Started: Feb 15, 2020 Primary completion: Mar 1, 2022 Completion: Mar 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03979937, this observational or N/A phase trial focuses on Arthritis and Joint Effusion and remains completed. Sponsored by Centre Hospitalier le Mans, it has been updated 7 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2022 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Oct 2021 — Apr 2022 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2020 — Jan 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jul 2019 — Apr 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier le Mans

Data source: Centre Hospitalier le Mans

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Le Mans, France